BSE filing, NSE: GLAXO. Summary written from the filing by ALFA Finder's alert engine.
GlaxoSmithKline Pharmaceuticals Ltd: key numbers
- Share price
- ₹2,515.10
- Market cap
- ₹42,607 Cr
- Revenue (annual)
- ₹3,822 Cr
- Net profit (annual)
- ₹1,036 Cr
- P/E (TTM)
- 39.9×Sector 48.7×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 4.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GlaxoSmithKline Pharmaceuticals Ltd
All →GlaxoSmithKline Pharmaceuticals Board Meeting Date
GlaxoSmithKline Pharmaceuticals Limited will hold a board meeting on 3rd November 2026 to consider and approve its unaudited financial results for the quarter ended 30th September 2026.
GlaxoSmithKline Pharmaceuticals Other Announcement
GlaxoSmithKline Pharmaceuticals Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI listing regulations.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GSK Pharma's postal ballot approved Ms. Natland as NED and Mr. Akshikar's MD re-appointment. Both resolutions cleared with over 99% shareholder support.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GlaxoSmithKline Pharmaceuticals issued a corrigendum for its August 3, 2026, postal ballot notice, correcting a typographical error in a reported salary figure.
GlaxoSmithKline Pharmaceuticals Price Movement Clarification
GlaxoSmithKline Pharmaceuticals clarified that recent trading volume increases are purely market-driven. The company confirmed all material disclosures have been made according to SEBI regulations.
GlaxoSmithKline Pharmaceuticals Business Update
GlaxoSmithKline Pharmaceuticals received an income tax refund intimation of Rs 4.99 Crore for the assessment year 2025-2026.
- Value
- ₹4.99 Cr
Other board meeting date announcements
All →G G Dandekar Properties Board Meeting Date
G. G. Dandekar Properties Ltd has scheduled a board meeting for November 4, 2026, to approve its financial results for the quarter and half-year ended September 30, 2026.
Jyoti CNC Automation Board Meeting Date
Jyoti CNC Automation Ltd will hold a board meeting on November 03, 2026, to approve standalone and consolidated financial results for the quarter ended September 30, 2026.
Generic Engineering Construction and Projects Board Meeting Date
Generic Engineering Construction and Projects Ltd scheduled a board meeting on November 3, 2026. The meeting will consider standalone and consolidated quarterly financial results.
Lemon Tree Hotels Board Meeting Date
Lemon Tree Hotels announced a board meeting on November 5, 2026, to consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026.
Powerica Board Meeting Date
Powerica Ltd scheduled a board meeting for November 5, 2026, to consider and approve financial results for the quarter and half year ended September 30.
Mehta Securities Board Meeting Date
Mehta Securities has scheduled a board meeting on 6 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window stays closed from 1 October 2026 until 48 hours after results.